Suppr超能文献

CD4(+) /CD8(+) T 细胞计数对儿童异基因造血干细胞移植后急性移植物抗宿主病发生的影响及 NK 细胞计数对结局的影响。

Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.

机构信息

Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Pediatr Blood Cancer. 2015 Mar;62(3):522-8. doi: 10.1002/pbc.25347. Epub 2014 Nov 21.

Abstract

BACKGROUND

Increasing evidence suggests that early and rapid lymphocyte recovery following allogeneic hematopoietic stem cell transplantation (HSCT) is associated with better survival.

PROCEDURE

We retrospectively analyzed very early lymphocyte subset counts following transplantation from our 5-year pediatric allogeneic HSCT material to find clinically relevant associations with post transplant outcome, and the major complication of HSCT, acute graft-versus-host disease (aGVHD). We analyzed HSCTs performed due to acute leukemias and lymphomas from matched unrelated donors (MUD, n = 33), unrelated cord blood (UCB, n = 9) and matched sibling donors (MSD, n = 17).

RESULTS

Patients with grafts from MUDs and grade II-IV aGVHD) had higher (median 2.1 compared to 0.3, P<0.0001) and earlier (at day +18 post transplant vs. day +25, P = 0.004) first measurable CD4(+) /CD8(+) T cell ratio, compared to patients with no or grade I aGVHD, respectively. At day +32 after HSCT patients with MUDs and significant aGVHD had higher levels of both CD4(+) and CD8(+) T cell subsets. Low (below median 120/µL) versus high natural killer (NK) cell counts at day +32 were associated with 3-year event-free survival of 27.4 +/- 9.0% versus 82.4 +/- 6.4% (P < 0.0001), cumulative transplant-related mortality of 44.7 +/- 12.2% versus 3.0 +/- 3.0% (P < 0.001) and cumulative relapse incidence of 50.4 +/- 12.2% versus 15.0 +/- 6.2% (P = 0.019), respectively.

CONCLUSIONS

We conclude that early lymphocyte subset counts following allogeneic HSCT have an association with aGVHD and post transplant outcome.

摘要

背景

越来越多的证据表明,异基因造血干细胞移植(HSCT)后早期和快速的淋巴细胞恢复与更好的生存相关。

方法

我们回顾性分析了来自我们 5 年儿科异基因 HSCT 资料的移植后非常早期的淋巴细胞亚群计数,以找到与移植后结果和 HSCT 的主要并发症——急性移植物抗宿主病(aGVHD)相关的临床相关关联。我们分析了来自非亲缘供体(MUD,n=33)、无关脐带血(UCB,n=9)和匹配同胞供体(MSD,n=17)的急性白血病和淋巴瘤患者的 HSCT。

结果

MUD 供体和 II-IV 级 aGVHD 患者的(中位数为 2.1 比 0.3,P<0.0001)和更早(移植后第 18 天 vs. 第 25 天,P=0.004)可测量的 CD4+/CD8+T 细胞比值更高,与无或 I 级 aGVHD 患者相比。在 HSCT 后第 32 天,MUD 供体和明显 aGVHD 患者的 CD4+和 CD8+T 细胞亚群水平更高。第 32 天自然杀伤(NK)细胞计数低(低于中位数 120/µL)与 3 年无事件生存率 27.4+/-9.0%与 82.4+/-6.4%(P<0.0001)、累计移植相关死亡率 44.7+/-12.2%与 3.0+/-3.0%(P<0.001)和累计复发率 50.4+/-12.2%与 15.0+/-6.2%(P=0.019)相关。

结论

我们得出结论,异基因 HSCT 后早期淋巴细胞亚群计数与 aGVHD 和移植后结果相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验